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To understand healthcare professionals’ experiences and perceptions of nurses’ potential
or ideal roles in pharmaceutical care (PC).
Design
Qualitative study conducted through semi-structured in-depth interviews.
Setting
Between December 2018 and October 2019, interviews were conducted with healthcare
professionals of 14 European countries in four healthcare settings: hospitals, community
care, mental health and long-term residential care.
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Participants
In each country, pharmacists, physicians and nurses in each of the four settings were inter-
viewed. Participants were selected on the basis that they were key informants with broad
knowledge and experience of PC.
Data collection and analysis
All interviews were conducted face to face. Each country conducted an initial thematic anal-
ysis. Consensus was reached through a face-to-face discussion of all 14 national leads.
Results
340 interviews were completed. Several tasks were described within four potential nursing
responsibilities, that came up as the analysis themes, being: 1) monitoring therapeutic/
adverse effects of medicines, 2) monitoring medicines adherence, 3) decision making on
medicines, including prescribing 4) providing patient education/information. Nurses’ auton-
omy varied across Europe, from none to limited to a few tasks and emergencies to a broad
range of tasks and responsibilities. Intended level of autonomy depended on medicine types
and level of education. Some changes are needed before nursing roles can be optimised
and implemented in practice. Lack of time, shortage of nurses, absence of legal frameworks
and limited education and knowledge are main threats to European nurses actualising their
ideal role in PC.
Conclusions
European nurses have an active role in PC. Respondents reported positive impacts on care
quality and patient outcomes when nurses assumed PC responsibilities. Healthcare profes-
sionals expect nurses to report observations and assessments. This key patient information
should be shared and addressed by the interprofessional team. The study evidences the
need of a unique and consensus-based PC framework across Europe.
Introduction
Effective team communication and clear definitions of roles are two of the fundamental pre-
requisites for effective collaboration among nurses, physicians and pharmacists to deliver high
quality care and better meet patients’ needs [1, 2]. Unclear role boundaries hinder collabora-
tion on different levels: quality of interprofessional communication and collaboration in daily
clinical practice; transnational collaboration in research, education and innovation; and labor
mobility of nurses [1–4]. A clear description of roles in pharmaceutical care (PC) and medi-
cines optimisation, however, is not always available [2, 5–7]. In this study PC is defined as
‘Healthcare professionals’ contribution to the care of individuals in order to optimize medicines
use and improve health outcomes’. This definition is based on the definition of the Pharmaceu-
tical Care Network Europe (PCNE) [8], which, however, was limited to the contribution of
pharmacists, as well as the original definition of Hepler and Strand in 1990 [9]. After all, the
need for interprofessional collaboration in PC is broadly recognised [3, 10–14].
Large variations in nurses’ roles exist, as was demonstrated in a cross-country comparative
study in 39 countries. In two third of the countries, nurses took up advanced roles from
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physicians, but the extent varied. A trend towards expanding nurses’ scope-of-practice in pri-
mary care was evolving [4]. The large variation in nurses’ roles was corroborated in the
EUPRON-study investigating nurses’ current clinical practices in interprofessional pharma-
ceutical care (PC). This showed that monitoring medicines effects, monitoring medicines
adherence, prescribing medicines and providing patient education/information about medi-
cines are already part of nurses’ clinical practice, and nurses’ contribution to PC differs
between countries, in both law and practice [13].
Nurses’ scope of practice is considered as the full range of roles, responsibilities and tasks
that nurses are educated, competent and authorized to perform [15]. Within this scope of
practice, a framework for nurses’ ideal roles in interprofessional PC would allow insights into
current and potential roles in PC, and facilitate discussions in clinical practice, education,
research, international comparisons, policy-making and legislation. Additionally, this frame-
work could be used to develop an assessment to evaluate nurse competences in PC, as a guid-
ance to evaluate nurse education, as a tool for nurse educators, for benchmarking and nurse
labour mobility. To date, we have not identified such a framework in the published literature.
To develop a robust framework, adapted to the needs of clinical practice, insights in the prefer-
ences of the most important stakeholders (nurses, physicians and pharmacists) are necessary.
Exploring those preferences, requires in-depth qualitative research.
This study is the second part of the DeMoPhaC project, an international Erasmus + collabo-
ration to investigate nurses’ role in interprofessional PC in 14 countries. Within this project
several large-scale quantitative and qualitative studies are being undertaken with healthcare
workers and nursing students. The overall aim of the project is the Development of a Model
for nurses’ role in interprofessional Pharmaceutical Care in Europe and the development of an
assessment to evaluate nursing curricula and final year nursing students’ competences in PC.
The first part of the project focused on the current clinical practice of nurses in PC without
insights into strenghts, weaknesses, opportunities and threats from nurses’ involvement in PC
[13]. In-depth qualitative research through case studies can close this gap. Therefore, we aimed
to perform a qualitative study, to understand pharmacists’, physicians’ and nurses’ experiences
and perceptions of nurses’ potential or ideal roles in PC.
By considering the ‘potential or ideal roles’, we aimed to investigate nurses’ responsibilities
and tasks within–but also beyond–nurses’ current legal scope of practice, taking into account
all necessary contextual factors.
Methods
Study design
This study was conducted and reported according to the Consolidated Criteria for Reporting
Qualitative Research (COREQ) [16].
We explored nurses’, physicians’ and pharmacists’ expectations about nurses’ role in PC,
and related strengths, weaknesses, opportunities and threats through a qualitative descriptive
research design with a phenomenological case study approach. Case study as a research
method has been widely used for preliminary and exploratory stages of research [17–19]. Mul-
tiple case studies allow cross-case comparisons and the identification of themes across cases. A
phenomenological approach using in-depth semi-structured interviews within the case studies
support high quality data collection [20–22]. Phenomenology is well suited for exploring per-
spectives of healthcare professionals [23]. This research approach was chosen as an appropriate
way to describe the essence of the phenomenon “nurses’ role in interprofessional PC”, by
exploring it from the perspective of those who have experienced it, namely pharmacists, physi-
cians and nurses themselves. Interviewing this study population enables studying and
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understanding healthcare professionals’ lived experiences in interprofessional PC. Only by
understanding their personal experiences and perceptions of nurses’ responsibilities and tasks,
and interprofessional collaboration and communication, we will be able to provide detailed
examination of the current strengths and weaknesses, together with the future opportunities
and threats from nurses’ involvement in PC [23].
Setting
The study took place in 14 European countries: Belgium, Czech Republic, Germany, Greece,
Hungary, Italy, the Republic of North Macedonia, the Netherlands, Norway, Portugal, Slova-
kia, Slovenia, Spain and the United Kingdom (England and Wales). In each country in-depth
interviews were conducted in four different settings: hospitals, community care, long-term res-
idential care, and mental health care.
Participants
‘Key informant’ pharmacists, physicians and nurses were purposively sampled [24]. They
could only be selected on the condition that they were named as expert in PC by at least two
other healthcare professionals, with local knowledge of PC, and insights into the nature of
problems and possible solutions. This allowed us to get information about nurses’ roles in
interprofessional PC and to understand the motivations and beliefs of a large number of
healthcare professionals with diverse backgrounds and opinions. Representatives of profes-
sional associations for nurses, physicians and pharmacists, and healthcare providers in differ-
ent healthcare institutions were asked to identify key informants. Researchers contacted the
persons identified as potential participants by email or telephone, informed them about the
study, and about being named as a key informant on nurses’ role in interprofessional PC. If
they agreed with being able to serve as a key informant, written information was provided to
fully inform the potential participants about the study details.
We aimed for at least two interviews per profession (n = 3) per healthcare setting (n = 4),
per country (n = 14), resulting in 24 in-depth face-to-face interviews per country. These num-
bers were aimed for in order to compile a sample with perspectives as diverse as possible. Data
saturation was reached in each participating country. There were no restrictions as to gender
or age. No reimbursement was provided for participation. Exact numbers of those approached
and declining were not registered in all countries.
Interview guide development
An interview guide (S1 Appendix) was developed in English based on literature and the results
of a previous quantitative study about nurses’ practices in interprofessional PC (Fig 1, step 1)
[13]. During a meeting with all European partners, the interview guide was adjusted until con-
sensus was reached (Fig 1, step 2).
To ensure conformity across twelve languages, the concept of PC was described at the
beginning of the interview: “healthcare professionals’ contribution to the care of individuals in
order to optimize medicines use and improve health outcomes”. This description was derived
from the Pharmaceutical Care Network Europe definition of 2013, taking into account the
interprofessional aspect of PC [8, 14].
Responsibilities and tasks were defined based on the literature, together with discussions
with an expert in health law, liability law and ethics and an expert in legal philosophy and eth-
ics: “The role of nurses involves several responsibilities. A responsibility for nurses is an obligation
that they have by virtue of their role as a nurse. Their central responsibility is to be the patient’s
health advocate and to provide high quality care, using sound professional judgement and taking
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Fig 1. International approach to increase methodological quality.
https://doi.org/10.1371/journal.pone.0251982.g001
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into account the relevant legal and moral considerations. The other responsibilities of nurses
derive from this central responsibility. Nurses can be made to answer for failing in their responsi-
bilities, which could result in disciplinary, civil, and criminal liability. Specific tasks may have to
be performed in order to fulfill a responsibility.” [25, 26].
The interview guide consisted of four main topics.
Topic 1: Responsibilities. Respondents were asked what responsibilities would be part of the
ideal role of nurses in PC and what these responsibilities would imply. Preparation and
administration of medicines by nurses was considered as an obvious part of PC and there-
fore outside the study’s scope. After open reflections, four responsibilities were presented:
1) monitoring and following-up of therapeutic and adverse effects of medicines; 2) moni-
toring and following-up medicines adherence; 3) decision making on medicines use,
including prescribing medicines, excluding preparation and administration; 4) providing
patient education and information about medicines. Respondents were asked what they
would like to change, add, or remove. This structuring ensured uniformity across 14 coun-
tries and 12 languages.
Topic 2: Tasks. Specific tasks within the previously defined responsibilities were elicited. A
similar strategy as above, with open and then more guided reflections, was used. The prede-
fined tasks for reflection were: 1) detecting clinical change, healthcare problems or assessing
patient needs; 2) registration; 3) interprofessional communication (including reporting,
alerting and discussion); 4) patient communication; 5) intervention in emergency cases; 6)
follow-up; 7) self-care support; 8) ‘dependent’ nurse prescribing; 9) ‘independent’ nurse
prescribing; 10) reporting medication errors and safety issues.
Topic 3: Interprofessional team working. Ideal communication and collaboration between
pharmacists, physicians and nurses, when aiming for high quality PC and predefined inter-
actions were suggested: 1) nurses reporting observations to physicians and pharmacists; 2)
physicians providing information and instruction to nurses; 3) pharmacists giving advice to
nurses.
Topic 4: SWOT analysis. Finally, respondents were asked to reflect on strengths, weaknesses,
opportunities and threats (SWOT) of nurses’ current and ideal roles.
Data collection
Nurse researchers in each country were trained in qualitative research and in-depth interview-
ing during a joint one-week training program at University of Antwerp in November 2019
(Fig 1, step 3). When agreed, the interview guide was translated into all national languages and
pilot tested in each country by at least one pharmacist, physician and nurse (Fig 1, step 4–5).
The test interviews were not included in the data analysis. No significant adjustments were
made after the pilot interviews. Between December 2018 and October 2019 interviews were
conducted by two to four interviewers per country (Fig 1, step 6). Participants were mostly
interviewed at their workplace, or another location, such as participant’s home or the research-
er’s workplace. Regardless of location, confidentiality was maintained. Only the interviewer
and the interviewee were present during the interview. Interviews lasted from 30 to 90 min-
utes, and were audio recorded. Field notes were taken. No interviews were repeated. Audio
recordings were transcribed verbatim by the interviewer or a professional transcriber (Fig 1,
step 7). They were not returned to participants for member checking.
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Data analysis
The qualitative analysis started after the first interview [27]. The transcripts were coded by
labelling lines of text in order to group and compare similar or related data segments. To create
an international code book for data analysis, 12 interviews were fully translated into English
and coded by the local researchers from 4 countries (one pharmacist, one physician, one nurse
per country) (Fig 1, step 8). The English codes were then collected to create a common first
code book, to be used as a guide for analysing subsequent interviews (Fig 1, step 9). Consensus
was achieved within the consortium, and the next 30 interviews were analysed (Fig 1, step 10–
11). Extra codes and themes could be added if new content arose. The final code book con-
sisted of 11 themes, combined with 49 sub-themes, addressing nurses’ roles and the related
SWOT analysis (S2 Appendix; Fig 1, step 12).
To improve the confirmability of the study, every first interview per professional group per
country was analysed by two researchers [28–30]. In that way, at least three interviews per
country (one nurse, one physician, one pharmacist) were analysed by two researchers. All
other transcripts and coding were at least checked by a colleague. After the data were analysed
at national level, by coding the transcripts, researchers in each country selected quotations for
each theme and sub-theme (Fig 1, step 14). To store the quotations, add labels and arrange the
data, Microsoft Excel1 tables were created. To accomplish an overall view on the data, the pre-
selected citations were reviewed by two researchers (first and second author) to reassess the
code labels for accuracy and to compare the different opinions throughout Europe. All
assumptions were taken into account, regardless the number of times they occurred (Fig 1,
step 16). The national data per country, as well as the overall international data, were presented
at an international meeting with all partners to discuss the completeness and interpretation of
the results per country, and achieve international consensus (Fig 1, step 17).
Ethics approval
The Ethics Committee for Social Sciences and Humanities of the University of Antwerp
approved the study design (reference SHW_19_30). Depending on local regulations in Slove-
nia, the UK and Portugal, additional approval was obtained from the Medical Ethics Commit-
tee of the Republic of Slovenia (reference 0120-516/2018/6), Health and Care Research Wales
(reference 19/HCRW/00) and the Ethics Committee of the Escola Superior de Enfermagem in
Coimbra (reference 543/12-2018). National regulations and laws applying to the other coun-
tries didn’t require additional permits or approvals. All respondents received information on
the purpose, design and execution of the study. Written informed consent was given by all
study participants.
Results
The characteristics of the 340 healthcare professionals interviewed are presented in Table 1:
113 pharmacists, 111 physicians and 116 nurses, employed in hospital care (45%), community
care (26%), residential care (14%), mental healthcare (9%), and other settings, such as a (10%).
Healthcare professionals involved were equally distributed across participating countries.
Most respondents worked in clinical practice (80%) and spent an estimated mean of 29 ± 15.1
hours/week on PC.
In response to questions about the ideal role of nurses in clinical practice, the four main
responsibilities, developed in previous work, remained substantially unchanged. Within each
responsibility, several tasks and contextual factors were reported. Opinions differed regarding
expectations of nurses. An overview of all nurse responsibilities and tasks in interprofessional
PC reported by pharmacists, physicians and nurses is given in Table 2.
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Responsibility 1: Monitoring therapeutic and adverse effects of medicines
Some respondents considered monitoring patients for the benefits and harms of medicines
administered as part of basic nursing care, whereas others disagreed.









The Netherlands 24 (7.1)
Norway 24 (7.1)
Portugal 24 (7.1)














Hospital care 154 (45.3)
Community care 88 (25.9)
Residential care 46(13.5)
Mental healthcare 29 (8.5)
Other / no specific healthcare setting�� 35 (10.3)
Main field�





Mean (SD) Median (min-max)
Age (years) 45.9 (10.6) 46.0 (24–76)
Expertise in main field (years) 19.1 (10.7) 18 (2–48)
Work related to pharmaceutical care (hours/week) 28.3 (15.3) 30 (1–105)
� Total is different from 100% because more than one answer was possible.
�� academic setting, education, research, politics, national health services, individual practice (not community care)
or not specified
https://doi.org/10.1371/journal.pone.0251982.t001
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“I think pharmacists are better placed to report about unwanted effects, since we are commit-
ted to report on pharmacovigilance. Pharmaceutical care is pharmacists’ work, and nobody
else’s”
(Pharmacist-05, Slovenia)
“The clinical evaluation and follow-up is something nurses currently do on a daily basis and
which is often the trigger of alarm to physicians. It is already part of nurses’ skills and it is
being done well.”
(Physician-01, Portugal)
Within monitoring, nurses’ tasks were defined as medication anamnesis, detecting clinical
change and healthcare problems and assessing patient needs. Early recognition of signals and
linking with medicines was seen as vital to patients’ safety. Reporting observations to the team
(physician and pharmacist) and to patients or their informal caregivers and family, as well as
registration and follow-up of medicines’ desirable and undesirable effects were recognized as
nurses’ tasks. Follow-up was suggested as either a nursing or shared responsibility or solely a
medical task.
“Pharmacists won’t notice side effects, only one person will–it’s the nurse.”
(Pharmacist-20, Hungary)
“Nurses don’t only distribute medicines like a trained monkey. They are able to realize that
somehow a problem could arise and preventive interventions might be necessary.”
(Nurse-04, Germany)
To monitor therapeutic and adverse effects of medicines, respondents perceived a certain
level of knowledge about medication to be needed, and therefore high quality nurse education
must be provided. In addition, some felt clear legal frameworks, policies and regulations, allo-
cating nurses clear roles in monitoring, are necessary.
Table 2. Existing or potential nurse responsibilities and tasks in interprofessional pharmaceutical care (beyond
medication preparation and administration).
Responsibilities Tasks
1. Monitoring therapeutic and adverse effects of medicines
2. Monitoring medicines adherence
3. Decision making on medicines use, including (de)
prescribing, medication reconciliation and medication
review
4. Providing patient education and information about
medicines
a. Detecting, addressing, reporting clinical change and
healthcare problems
b. Assessing patients’ needs
c. Identifying, reporting and addressing drug related
problems and safety issues
d. Follow-up assessments of patients
e. Intervention in emergencies
f. Documentation in patient records
g. Communication with patient, informal caregiver
and family
h. Selfcare support and therapeutics education
i. Interprofessional communication, including
reporting, advising, informing, alerting and discussing
j. Communication within the nursing team
k. Supervising and coaching new healthcare workers
and less qualified team members
https://doi.org/10.1371/journal.pone.0251982.t002
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Responsibility 2: Monitoring medicines adherence
Many respondents considered adherence monitoring to be a clear and obvious aspect of
nurses’ roles, while some were convinced that this was a physician-only responsibility or even
the sole responsibility of the patient.
“Monitoring and following-up medication adherence, this is probably clear. This is an area
which is the least controversial, I see no problem in it.”
(Nurse-12, Czech Republic)
Within monitoring medication adherence, one important nursing task was to detect and
alert the interprofessional team of any non-adherence. Nurses may also motivate patients to
adhere to their prescribed regimen. Motivational interviewing of patients with targeted open
questions would identify reasons of non-adherence, determine patients’ needs, and support
self-care.
“When the nurse is with the patient, she realizes whether the pill is too big for the patient and
he would prefer to take two smaller ones twice a day.”
(Pharmacist-02, Italy)
Prerequisites of adherence monitoring by nurses included: clear guidelines about the
responsibilities of nurses, pharmacists and physicians in monitoring adherence within a legal
framework; open, blame-free culture; open dialogue between pharmacists, physicians and
nurses; appropriate nurse training in PC; and a manageable workload, resulting in time to care
and explore issues with patients.
Responsibility 3: Decision making on medicines use, including (de)
prescribing, medication reconciliation and medication review
A wide variation in opinions was reported, with more positive views in countries with existing
nurse prescribing. Differences in opinion were not confined to any one profession. A small
number of respondents considered nurses already possessed the required competences, and
advocated nurse-prescribing for a wide range of medicines, usually within their specialist
fields.
“Doctors, especially in hospitals, got used to giving their stamps to the head nurse to write
prescriptions.”
(Pharmacist-01, Greece)
“We have an internal deal with the nurses on my ward, that they are allowed to give some
medicines to patients on their own, under specific circumstances and specific medicines that
we agreed on.”
(Physician-06, Slovenia)
Others favoured nurse prescribing, but only after extra training and under specific condi-
tions, e.g. emergencies, low risk medicines (often those that can be purchased without a pre-
scription) or confined to nurses with high levels of nursing education. A further group would
never–under any circumstances—give nurses a role in decision making or prescribing. They
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considered this responsibility to be too complex and a medical responsibility, in which collabo-
ration with nurses was not desirable.
“Experiences with nurse prescribing in other countries are not of that kind, that we need to be
scared of it.”
(Pharmacist-02, Belgium)
“It scares me. . . it is probably just my feeling. . . I cannot imagine nurse prescribing.”
(Pharmacist-10, Czech Republic)
Respondents considering decision making on medicines to be a part of nurses’ ideal roles
described possible tasks within this responsibility: nurses could decide on the route, formulation
and brand; add or deprescribe treatments; adjust and titrate doses; prepare prescriptions (to be
validated by a physician); and prescribe repeat prescriptions. Respondents predominantly
reflected on the selection of products, the level of autonomy and the level of emergency: local
and low-risk medicines from a limited list were preferred to systemic and high-risk medicines;
supervision by physicians or pharmacists and shared responsibility were favoured above full
autonomy for nurses; and life-threatening emergencies warranted increased autonomy. Others
felt that more complex thinking is required in these situations, arguing against more responsibil-
ity for nurses. There were calls for flexible practice guidelines. Knowledge was mentioned as a
crucial prerequisite for decision-making in PC. As an initial step, more pharmacology is needed
in pre- and post-registration nurse education. Level 6 (Bachelor) nurses [31], nurse specialists
and nurse practitioners were suggested as having the minimum level of education to prescribe.
“Nurse prescriptions should be very limited. I would understand nurse prescribing, but only in
very specific restricted situations.”
(Pharmacist-03, Spain)
“What responsibilities would be part of the ideal role of a nurse in interprofessional pharma-
ceutical care? In my ambulatory practice I think nurses can prescribe ‘repeating prescriptions’
within control consultations. I think nurses can decide about routine medicines, within a cer-
tain spectrum, within their specialization in the field.”
(Physician-22, Slovakia)
“Nurses could have autonomy on the renewal of chronic therapies, previously prescribed by a
doctor.”
(Nurse-10, Italy)
“Nurses have the right to give emergency therapy when the patient’s life is endangered, e.g. in
case of major bleeding.”
(Nurse-02, Republic of North-Macedonia)
“I would increase the level of knowledge, because if we don’t have the proper level of knowl-
edge, we can’t prove to doctors and pharmacists that we are competent to prescribe and right
now they don’t trust us enough to prescribe.”
(Nurse-07, Slovenia)
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Responsibility 4: Providing patient education and information about
medicines
Some respondents were convinced that responsibilities for educating and informing patients
were the professional territory of physicians or pharmacists, while others believed these
responsibilities should be shared with nurses. Opinions were based on the very limited content
in pharmacotherapeutics in nurse education.
“Patient education about medicines would be better done by a pharmacist, they go to school
for 5 years and learn everything about medicines, while nurses have only one course in
school.”
(Pharmacist-01, Slovenia)
With improved education, nurses could: explain medical diagnoses; inform patients and
their caregivers about short- and long-term advantages and disadvantages of their medicines;
support self-care; counsel patients at discharge; encourage and empower patients to take their
medicines.
“A nurse has a responsibility to the patient to keep the patient fully informed about what has
been prescribed, the risks associated, side effects associated and benefits likewise.”
(Physician-04, UK)
“I think patient education and providing information is already done, it is common that
nurses educate patients. We can discuss about the quality and the way, but I think, the role of
nurses should be enhanced here.”
(Nurse-12, Czech Republic)
“Nurses should provide patient education and information on drugs, because doctors are too
complicated for patients.”
(Nurse-02, Slovakia)
Interactions between nurses, physicians and pharmacists in an ideal
interprofessional collaboration
Interprofessional communication, including reporting, advising, informing, alerting and dis-
cussing was considered of major importance in interprofessional PC. Collaboration, coaching
and supervising within the nursing team was also reported as important.
“Multidisciplinary communication works, nurses are irreplaceable, they ensure that informa-
tion and documentation is effectively passed between team members.”
(Nurse-03, Slovakia)
“Three-dimensional communication is missing. Clinical pharmacists have been collaborating
mainly with physicians, discussion with nurses is missing.”
(Physician-10, Czech Republic)
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Contextual factors allowed nurses to have a role in interprofessional collaboration, e.g. con-
fidence in nurses’ knowledge, self-confidence of nurses, an open blame-free culture, clear roles
and responsibilities, availability of team members, involvement of nurses in PC team meetings,
absence of hierarchic attitudes, and equality between professionals. Written communication
was recommended to ensure proper communication.
“The working atmosphere is crucial. This must ensure openness and honesty and give room
for clear feedback to each other.”
(Physician-08, the Netherlands)
“I don’t know who my nurses are in my two local surgeries. It would be nice to know their
names, I don’t think that’s the nurses’ fault I think it’s the way we get used to working.”
(Pharmacist-24, UK)
Strengths, weaknesses, opportunities and threats of nurses’ role in
interprofessional PC
Strengths. The proximity of nurses to patients was a strength of nurses’ contribution to
PC. Nurses spend a lot of time with patients and these frequent contacts could facilitate screen-
ing for symptoms, monitoring adherence, making decisions and informing or educating
patients and their informal caregivers.
“The nurse regularly visits the patient and therefore is the first in line to recognize adverse
effects of medicines and to act upon them. Physicians don‘t spend as much time near the
patients’ beds, so, they don’ t always see the effect of medicines, compared to a nurse on a
ward, who walks in the patient’s room for about 10 times a day.”
(Physician-23, the Netherlands)
Nurses were seen as well-positioned to take up responsibilities in interprofessional PC.
They have key information to share, which can trigger interventions by themselves or other
team members, in order to optimize medication use and improve health outcomes. Nurses’
reinforcement of physicians’ words to patients is important in their role in patient education.
“I, as a pharmacist, I am a real expert in medication. The GP is an expert in pathology. But
nurses, they are ‘the eyes’ because they SEE patients, they can report to other professionals.
Without you, nurses, the healthcare sector is dead. Without you, we are nothing!”
(Pharmacist-05, Belgium)
Weaknesses. Firstly, the absence of a legal framework for nurse’s roles in PC was evident
in several countries. Some professionals reported absence of diagnostic mindsets, PC compe-
tences and poor education. Inadequate education promoted a lack of confidence in nurses
from some pharmacists, physicians and nurses. Open dialogue with adequate interaction
between nurses, pharmacists and physicians seemed to be missing. Although respondents
believed that there was more communication than in the past, some hierarchical attitudes
persisted.
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“There must be an open dialogue, without throwing remarks, such as ‘I am a professional, I
am first, you are last.’ An open dialogue to be able to say ‘Hey guys, who can deal with this
part?’ It’s a puzzle. A brainstorming session to create clear abilities and job descriptions.”
(Pharmacist-01, Greece)
Opportunities. Further, opportunities for nurses’ roles in an ideal interprofessional PC
were identified. Each professional looking at the patient from his/her own perspective makes
the involvement of multiple professionals of added value. Nurse consultations to monitor
medicines effects and adherence, and care coordination by nurses were suggested as facilitators
of PC. This would align complementary knowledge of team members, and reduce contradic-
tory messages from different professionals.
"I could not imagine independent prescribing, because of interactions between body systems.
A nurse alone cannot order pharmaceuticals, but a team is involved. Each team member has
its own perspective; putting knowledge together will lead to much better results.”
(Nurse-11, Hungary)
“Multidisciplinary teams are the ones who do all the work. It is never a one man’s success.
Nurses have the capacity to lead, gather and organize multidisciplinary collaborations for the
patient’s benefit.”
(Nurse-02, Greece)
Nurses taking up more responsibilities in PC could have a positive impact on care quality
and patient outcomes: an increase of professional support for patients (including in areas
where few physicians are available e.g. rural or post-industrial areas), a substitute for physi-
cians’ input, reduction of waiting times and stress for patients, and, in case of nurse prescrib-
ing, a facilitation of prescription changes in emergencies.
“I completely agree that making decisions on medicines would take some weight off doctors
shoulders”
(Physician-04, Slovenia)
“The benefits of interprofessional co-operation with nurses, pharmacists and physicians are
rapid response, patient satisfaction and quality of care.”
(Nurse-02, Republic of North-Macedonia)
In addition, shared digital patient files, interprofessional ward rounds and integrating inter-
professional collaboration and communication into education of all professionals would be
great opportunities for the future.
“Training with all the professionals is needed, we finish our degree without connecting directly
to the other professionals and that is not what we see in the practice.”
(Nurse-02, Spain)
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Threats. However, lack of time (to care), shortage of nurses and limited financial compen-
sation for the time spent in PC roles, in combination with the current high burden of nursing
responsibilities threaten the realisation of nurses’ ideal roles in PC.
“I don’t understand why things should change, nurses want to prescribe and they don’t even
have time to do what they are already competent to do. . .”
(Pharmacist-01, Slovenia)
“Those who bear more responsibility should also receive more money, which is not yet the case
in today’s collective agreements.”
(Nurse-06, Germany)
Finally, the absence of a legal framework for nurses’ roles and some physicians or pharma-
cists worrying about “their territory” in PC must be addressed.
“Interactions should be more lubricated and should be encouraged and I think they should be
even legislated because it seems that nobody does anything if it is not an obligation. . . in order
to boost public health. . . but a diagram needs to be made for people understood how it works..
so it will be better to be legislated. . ..”
(Pharmacist-06, Portugal)
“The barriers are quite clear, professional conflicts have always been there. Every time one
tries to get into a subject to another profession then they put up a stop that “this is my area of
responsibility, you shouldn’t have anything to do with”.”
(Nurse-01, Norway)
“My experience is that hospital nurses think they are like physicians and I don’t like it. They
are also elevated to us as pharmacists, while the role of both our professions is very important.
Everybody is better in different area and nobody is the subordinate.”
(Pharmacist-02, Slovakia)
Discussion
Four main responsibilities for nurses in PC were evaluated. Many different tasks were
described as part of nurses’ ideal practice, yet many professionals were ambivalent over their
implementation.
The extent of nursing autonomy depended on type of medicine and country-specific gover-
nance structures, and varied from no authority to authority and responsibility for broad ranges
of activities. Not every nurse would be capable of performing every task in every situation. Sev-
eral contextual factors should be taken into account while translating nurses’ ideal roles in PC
into clinical practice. Important prerequisites which were also already discussed in the litera-
ture were: sufficient education [32, 33], knowledge (more pharmacology and pharmacothera-
peutics) [34, 35], an interprofessional collaborative approach [1, 36], confidence in nurses [37,
38], an open blame-free culture with clarity of team composition and roles [39, 40], equality
between professionals [41], adjusted legislation [42], readiness of professionals and patients to
allow nurses to have responsibilities in PC [43], and a manageable workload leaving “time to
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care” [44, 45]. Lack of time, shortage of nurses, absent legal frameworks and limited education
and knowledge were described as main threats. However, a positive impact on care quality and
patient outcomes was associated with nurses taking up responsibilities in PC. Nurses’ observa-
tions and assessments could convey key patient information to the interprofessional team, as
was also shown in previous research [46].
Fourteen countries were included in the study. Despite all of these being in Europe, it can-
not be assumed that the education of nurses in each of these countries is uniform. A systematic
review of nurse education in European presented differences on both level and duration of
education [33]. Two thirds of all nursing education programs are offered at the higher educa-
tion level, while one third is offered at diploma-level. The duration of full-time nursing educa-
tion programs varies from two to four years, with the majority (58%) lasting for three years.
Also, different education pathways lead to the same level of nursing qualification in some
countries and specialist qualifications are offered at both undergraduate and graduate degrees
[33]. Although the participants in this study raised the issue of the need for sufficient education
before nurses could have a role in pharmaceutical care, experiences on the specific differences
between the levels of education in each country were not addressed in the interviews. Only for
nurse prescribing did some respondents formulate minimum conditions in terms of educa-
tional level. Further research investigating differences in nursing responsibilities between lev-
els of nurse education can offer significant added value to the development of a framework for
level-specific roles of nurses in interprofessional PC.Nurses’ roles have expanded in Europe
over the last decade. An international comparative analysis of reforms of nurse prescribing
concluded that 13 European countries already had legislation on nurse prescribing, eight since
2010. The extent of prescribing rights ranged from nearly all medicines within nurses’ speciali-
sations to a limited set of medicines. All countries had regulatory and minimum educational
requirements in place to ensure patient safety; the majority required some form of physician
oversight [47]. Our study included four countries with legal prescribing rights for some nurses
or some products at the time of data collection: the Netherlands, Norway, Spain and the
United Kingdom. Different participant perspectives, however, were not related to country or
any one profession.
Regardless of whether or not nurses are able to prescribe, they can have a pivotal role in ini-
tiating and supporting deprescribing [48, 49]. However, nurses’ roles in providing patient
information about deprescribing are not always well considered, but nurses may be as effective
as physicians at discussing medicines discontinuation with patients [50]. When nurses are
aware of the medicines that are most appropriate for deprescribing, for example antipsychotics
for behaviour disturbance, they can monitor these patients to ascertain the benefits no longer
outweigh the harms [48, 49].
We consciously chose to start the interviews with a definition of PC. This strategy has both
advantages and disadvantages. Predefining PC ensured uniformity across 14 countries and 12
languages. On the other hand, we were unable to extract the participants’ conceptualizations of
the definition. However, we did encourage open reflections about the interpretation of role ful-
filment within PC. The phenomenological approach of this study incorporates the supposition
that there may be multiple truths or realities as perceived by multiple participants [51, 52].
Additionally, the conceptualization of PC responsibilities may differ between healthcare pro-
fessionals, as was already investigated for the concept of ‘medication monitoring’ [53]. Moni-
toring from a nursing perspective is a dynamic, ongoing, day-to-day activity, while
pharmacists and physicians typically associate monitoring with structured medication reviews
and an intermittent, planned activity [53]. In our study, we were unable to explore any differ-
ences in how the concepts or themes were conceptualised by participants. Nevertheless, we
described many ambiguous opinions on PC responsibilities and tasks, and participants
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elaborated on a broad range of subthemes that needed to be specified in order to define nurses’
role in PC.
Strengths and limitations
To our knowledge, this is the first pan-European qualitative interview study about PC by
nurses. The quality of the research can be demonstrated based on the qualitative research qual-
ity criteria of Lincloln and Guba [28]. Firstly, triangulation of sources and analyst triangulaton
indicate credibility. Secondly, the extensive focus on the PC context of the participants result-
ing in thick descriptions will facilitate transferability of the study findings. Thirdly, the depend-
ability is confirmed by investigator triangulation: coding of the first interviews by multiple
researchers within one country, plus a non-country specific reassessment of the code labels
linked to preselected citations by a team of researchers.
The confirmability of this research could only be partially achieved. Researchers from all
countries were trained in qualitative research, in-depth interviewing, and ‘bracketing’ their
own beliefs about nurses’ role in PC during a joint one-week training program. However,
since interviewers and respondents often shared work environments, contextual intersecting
relationships between the participants and the researchers cannot be ignored. As we wanted to
avoid the profession of the researchers influencing the responses from physicians, pharmacists,
and other nurses, interviewers were asked not to inform interviewies about their profession
unless directly questioned [54].
Another limitation is the absence of structured integration of the field notes, that have been
made during the process of transcribing, critical reflecting and coding. Therefore, the research-
ers might have missed important non-verbal indicators, such as participants’ body language
and tone of voice.
The selected participants were ‘key informant’ experts in PC, who knew best what was hap-
pening in PC in clinical practice. However, findings cannot be generalised to more junior cli-
nicians or managerial staff. No reimbursement was provided for participation, leading to
occasional refusal to participate. Exact numbers of those declining to participate were not reg-
istered, leading to an unknown selection bias. Despite the limited number of participants per
professional group at national level, no new themes were generated in the last interviews
reviewed, suggesting sufficient information power [55]. Socio-cultural influences, mainly in
terms of attitudes towards other professions might affect perspectives related to interprofes-
sional collaboration, as was demonstrated in several studies [43, 56]. In this research, no infor-
mation was sought on cultural and/or ethnic identities of respondents. We wished to avoid
sensitive questions and any possibility that respondents might be identified by local readers.
Diversity should be taken into account in future research.
Implications for clinical practice and future research
Our results offer opportunities to create a framework for discussion in clinical practice, collab-
oration in research, and labour mobility. Nurses, pharmacists and physicians should openly
discuss allocation of specific responsibilities and tasks. Our list of responsibilities and tasks is
not exhaustive. Medication safety management [57], care coordination [58], overseeing patient
medication self-management [59, 60], assessing patients’ competences [61], coaching and
training patients [62], discharge planning [63] and interprofessional referrals [64] are addi-
tional nursing responsibilities and tasks identified in the literature. A scoping review of
research about PC by nurses would be useful to confirm the completeness of the role described
or supplement with additional responsibilities and tasks. Further research should also address
the differences in nurses’ roles within different levels of nurse education.
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Exploring nurses’ ideal role in PC is not intended to remove responsibilities from other pro-
fessional groups. On the contrary, the benefits of interprofessional collaboration and commu-
nication between pharmacists, physicians and nurses and its major impact on care quality and
patient outcomes have already been amply demonstrated [48, 49, 65–69]. Yet, healthcare sys-
tems are historically hierarchical in nature with physicians regularly assuming leadership posi-
tions and decision-making roles. Frustrations, lack of confidence, lack of organization and
structural hierarchies hinder interprofessional relationships and communication [41]. Power
imbalance between professions is an important factor in nurses’ professional roles when dis-
cussing PC and its formalisation. To address this source of conflict, it may be helpful for team
members to discuss and agree roles and responsibilities [40]. Increasing the awareness of all
team members’ potential roles would allow pharmacists, nurses and physicians to benefit from
teamwork [65]. Also, educators hesitate to address the reality of hierarchies in healthcare [70].
The training of healthcare professionals remains largely single discipline, which may reduce
the ability to collaborate interprofessionally [71]. Therefore, we call for more interprofessional
education, as well as rigorous research on interprofessional PC to tackle the remaining
barriers.
Conclusion
Nurses have an active role in monitoring patients for the impact of their medicines, monitor-
ing adherence, making decisions on medicines, and providing patient education and informa-
tion. Different tasks within these responsibilities have been described, although contextual,
knowledge and training factors have to be considered before nurses can perform this ideal
role. Lack of time, shortage of nurses, an absent legal framework and limited education and
knowledge were the main threats for nurses’ roles in PC. Nevertheless, a positive impact on
care quality and patient outcomes was associated with nurses taking up responsibilities in PC.
Nurses’ observations and assessments could lead to key information about patients being
shared and addressed by the interprofessional team. The outcomes of this study evidence the
need for a consensus-based PC framework across Europe.
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